mij821

Small moleculeexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Feb 8, 2019 (NCT03756129)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05666687Phase 1Jan 11, 2023Novartis, Parexel
NCT05454410Phase 2Jan 4, 2023Novartis
NCT04722666Phase 2Jul 20, 2021Novartis
NCT03756129Phase 2Feb 8, 2019Novartis
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
NovartisFor profit4422019
ParexelFor profit1012023
2 organizations
Page 1 / 1